IVD Contract Manufacturing Services Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Meticulous Research®—a leading market research company, published a research report titled, 'IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular Diagnostics, Clinical Chemistry, Hematology, Microbiology, Urinalysis) – Global Forecast to 2031’
According
to this latest publication from Meticulous Research®, the IVD contract manufacturing services market is projected to
reach $25.80
billion by 2030, at a CAGR of 7.8% from 2024 to 2031. The growth of the IVD
contract manufacturing services market is driven by several factors, including
the rising prevalence of infectious diseases, the shift in focus from
centralized laboratories to point-of-care testing services, regulatory
complexities faced by IVD companies, and the need for cost-effective
manufacturing of IVD tests. Factors such as high economic growth and increased
outsourcing to emerging countries serve as an opportunity that would help grow the
market in the future.
Factors
such as the lack of skilled professionals could be considered as a challenge
for the IVD contract manufacturing services market. However, maintaining
product quality and protection of proprietary information restrains the growth
of the market.
Key Players
The key
players profiled in the IVD contract manufacturing services market report are
Cenogenics Corporation (U.S.), In-Vitro Diagnostic Developers, Inc. (IDxDI)
(U.S.), Savyon Diagnostics (Israel), KMS Systems, Inc. (U.S.), Nova Biomedical
(U.S.), LRE Medical (Germany), Cone Bioproducts (U.S.), Invetech, Inc.
(Australia), Avioq, Inc. (U.S.), TCS Biosciences Ltd. (U.K.), Affinity Life
Sciences, Inc. (U.S.), Coris BioConcept (Belgium), Meridian Bioscience, Inc.
(U.S.), Affinity Biologicals, Inc. (Canada), Biokit S.A. (Spain), Merck KgaA
(Germany), Thermo Fisher Scientific, Inc. (U.S.), and Maxim Biomedical, Inc.
(U.S.).
The IVD
contract manufacturing services market is segmented by Type (Assay Development
Services, Manufacturing Services, and Other Services), Category (Reagents &
Consumables and Instruments & Systems), Technology (Immunoassay, Molecular
Diagnostics, Clinical Chemistry, Hematology, Microbiology, and Urinalysis), and
Geography. The study also evaluates industry competitors and analyzes the
regional and country-level markets.
Based on type, in 2024, the
manufacturing services segment is expected to account for the largest share of
the market. Manufacturing services are services that include ISO-certified
manufacturing facilities that allow them to carry out full project and
production management, quality and regulatory support, and flexibility in scale
and process, which results in increased demand for manufacturing services.
Based on category, in 2024, the
reagents & consumables segment is expected to account for the
largest share of the market. Reagents & consumables are products that are
used for the in-vitro examination of specimens derived from the human body
during disease diagnosis, treatment monitoring, prognosis, and evaluation of
the patient’s health status. The large market share of the segment is
attributed to factors such as increasing virulence of infectious diseases,
growth of companion diagnostics, and rapid growth in molecular testing, which
leads to an increased demand for POC diagnostic kits, therefore increasing the
use of reagents & consumables used in the tests.
Based on technology, in 2024, the
immunoassay segment is expected to account for the largest share of the market.
The large share of the segment is attributed to factors such as a higher
preference for immunodiagnostics owing to its inherent specificity, high
throughput, and the emergence of advanced diagnostic immunoassay formats.
Further, the increasing use of immunoassays in Point of Care (PoC) infectious
disease testing, the need for developing novel tests, increasing usage of
miniaturized devices, rising demand attributed to an aging population, and the
rising trend of automation in immunoassay instruments are driving the growth of
this segment.
This
research report analyzes major geographies and provides a comprehensive
analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy,
Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of
Asia-Pacific), Latin America and the Middle East & Africa. In 2024, North
America is expected to account for the largest share of the IVD contract
manufacturing services market, followed by Europe and Asia-Pacific. North
America’s major market share is attributed to the rising prevalence of various
infectious diseases, the growing healthcare sector, increasing awareness
regarding early disease diagnosis, growing adoption of advanced innovative
products, and increasing funding activities coupled with novel advanced
diagnostic technologies.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5226
Key questions answered in the report:
· Which are
the high-growth market segments in terms of IVD contract manufacturing services
type, category, technology, and geography?
· What was
the historical market for IVD contract manufacturing services across the globe?
· What are
the market forecasts and estimates for the period 2024–2031?
· What are
the major drivers, restraints, opportunities, and challenges in the IVD
contract manufacturing services market?
· Who are the
major players in the IVD contract manufacturing services market?
· What is the
competitive landscape, and who are the market leaders in the IVD contract
manufacturing services market?
· What are
the recent developments in the global IVD contract manufacturing services
market?
· What are
the different strategies adopted by the major players in the global IVD
contract manufacturing services market?
· What are
the geographical trends and high-growth regions/countries?
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment